not tagged
not tagged
['nsclc', 'sclc']
ahn: analysis of outcomes based on ctdna presence and clearance in egfr mutant nsclc. no use of tkis, adjuvant chemo mainly used. ctdna pos and lack of clearance is bad prognostically. #esmo22 
Medical Oncologist, Translational Researcher, Peter Mac. Tweets are my own opinions. Musician (@mayhemtomi) https://t.co/f3ccD2Ml7v